Royalty Pharma partners with J&J on $500M drug development deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. CIEN
9. GWRE
10. CPB

Go back to Royalty Pharma partners with J&J on $500M drug development deal
Johnson & Johnson (NYSE: JNJ) Delayed: 276.41 -2.02 (0.73%)
Previous Close $278.43    52 Week High $126.07 
Open $275.13    52 Week Low $94.28 
Day High $277.80    P/E 57.47 
Day Low $274.75    EPS $4.81 
Volume 1,483,627       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 64.08 +0.20 (0.31%)
Previous Close $63.88    52 Week High $3.48 
Open $63.55    52 Week Low $0.80 
Day High $64.38    P/E N/A 
Day Low $63.43    EPS $-1.54 
Volume 1,196,163